MedCity News

3 Health Investors Share Their Most Controversial Indus...

From AI to value-based care, three VCs shared their controversial takes on healt...

How a Tiny Federal Agency Supports Innovation & Competi...

The law that created ASTP as a formal federal agency gave it duties such as supp...

Payments Simplified: The 4 Key Features of Modern Healt...

Simplifying payments isn’t just about transactions; it’s about building better r...

The Changing Landscape of Ransomware: Why Healthcare Or...

Threat actors continue to refine their strategies, and the financial incentives ...

The Role of Consultants in Tackling Healthcare Expenses

[Sponsored] To ensure effective cost mitigation, employers can’t wait for the ma...

23andMe Bankruptcy Auction Win Adds Big Piece to Regene...

Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s...

How One Company Aims to Save Lives with Its Smartwatch

ZEM Life is developing a smartwatch that can deliver Narcan to combat a fentanyl...

How One Startup Is Standing Out in the Crowded AI Scrib...

To scale clinical AI, vendors must design tools that feel natural and personaliz...

Why Agentic AI Is Not Quite Ready for Primetime in Heal...

We need to evaluate agentic AI through the specific lens of the healthcare indus...

5 Companies That Offer Mobile IV Therapy With Experienc...

[Sponsored] Get your IV treatment from wherever you are. These top companies pro...

The Influence of Digital Transformation and AI in the F...

Today’s healthcare industry is evolving, which highlights the essential need to ...

How Smarter AI Strikes Back for Hospitals

[Sponsored] In an interview with MedCity News, Smarter Technologies CEO Jeremy D...

Sleep Apnea Relief in a Pill: Apnimed Drug’s Phase 3 Da...

Apnimed’s obstructive sleep apnea drug reduced breathing interruptions in a Phas...

Cleveland Clinic Digital Chief: Pick AI Problems That C...

Ensuring buy-in from end users is critical to hospitals’ AI success. To achieve ...

Alzheimer’s Disease Now Has Its First FDA-Cleared Blood...

Fujirebio Diagnostics’ blood test for Alzheimer’s disease offers a less expensiv...

Connected Care, Shared Goals: Designing Whole-Person Ca...

As the safety-net landscape shifts and funding uncertainty grows, the path forwa...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.